Si-Bone (SIBN) FCF Margin Growth (3y) (2020 - 2026)
Si-Bone (SIBN) FCF Margin Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 38.00 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 30.00 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 943.00 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 96.00 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -2,196.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -20.00 |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 2,679.00 |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -461.00 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 417.00 |
| 10 | Si-Bone | 696.98 Mn | 556.86 Mn | 41.94 Mn | 3,527.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,527.00 |
| Dec 31, 2025 | 338.00 |
| Sep 30, 2025 | 4,388.00 |
| Jun 30, 2025 | 6,835.00 |
| Mar 31, 2025 | 5,558.00 |
| Dec 31, 2024 | 6,853.00 |
| Sep 30, 2024 | 864.00 |
| Jun 30, 2024 | 3,283.00 |
| Mar 31, 2024 | 2,996.00 |
| Dec 31, 2023 | 3,239.00 |
| Sep 30, 2023 | 4,421.00 |
| Jun 30, 2023 | 3,777.00 |
| Mar 31, 2023 | 1,516.00 |
| Dec 31, 2022 | 4,953.00 |
| Sep 30, 2022 | 1,040.00 |
| Jun 30, 2022 | -976.00 |
| Mar 31, 2022 | -2,220.00 |
| Dec 31, 2021 | -429.00 |
| Sep 30, 2021 | -666.00 |
| Jun 30, 2021 | -3,836.00 |